People · Operator
Named in public records as an officer, director or promoter · active 2016–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Amarillo Biosciences Inc | — | Biotechnology | Series B | $21.8M | $565.6M | 2016 |
NICHOLAS MOREN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside NICHOLAS MOREN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| STEPHEN CHEN | 1 | 3 |
| PAUL TIBBITS | 1 | 1 |
| DANIEL FISHER | 1 | 1 |
| BERNARD COHEN | 1 | 1 |
| YASUSHI CHIKAGAMI | 1 | 1 |
| Chun-Hsien Tsai | 1 | 1 |
| EDWARD L MORRIS | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.